CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader Read more »